Pharsight

Amlodipine Besylate patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6828339 SYNTHON PHARMS Amlodipine salt forms and processes for preparing them
Nov, 2022

(1 year, 6 months ago)

Amlodipine Besylate is owned by Synthon Pharms.

Amlodipine Besylate contains Amlodipine Besylate.

Amlodipine Besylate has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Amlodipine Besylate are:

  • US6828339

Amlodipine Besylate was authorised for market use on 27 September, 2007.

Amlodipine Besylate is available in tablet, orally disintegrating;oral dosage forms.

The generics of Amlodipine Besylate are possible to be released after 20 November, 2022.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using AMLODIPINE BESYLATE ingredient

Market Authorisation Date:

27 September, 2007

Treatment:

NA

Dosage:

TABLET, ORALLY DISINTEGRATING;ORAL

More Information on Dosage

AMLODIPINE BESYLATE family patents

Family Patents